Lessons Learned from the Edrecolomab Story: How a Checkered Past Became a Checkered Flag for Monoclonal Antibodies in Colorectal Cancer Therapy

Publisher： Karger

E-ISSN： 2296-5262|28|6-7|311-312

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.28, Iss.6-7, 2005-06, pp. : 311-312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Toward an individualizing therapy for colorectal cancer: the example of the anti-EGFR monoclonal antibodies

By Lièèvre Astrid   Laurent-Puig Pierre  

Personalized Medicine, Vol. 6, Iss. 2, 2009-03 ,pp. : 145-157

Future Medicine

Access to resources Recommend Favorite

Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe

By Zhao Zhongyun   Pelletier Elise   Barber Beth   Bhosle Monali   Wang Song   Gao Sue   Klingman David  

Current Medical Research and Opinion, Vol. 28, Iss. 2, 2012-02 ,pp. : 221-229

Informa Healthcare

Access to resources Recommend Favorite

The Effect of Edrecolomab (Mo17-1A) or Fluorouracil-Based Chemotherapy on Specific Immune Parameters in Patients with Colorectal Cancer

By  

Oncology, Vol. 67, Iss. 5-6, 2005-02 ,pp. : 403-410

Karger

Access to resources Recommend Favorite

‘Conditioning the heart’ – lessons we have learned from the past and future perspectives for new and old conditioning ‘drugs’

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 8, 2015-04 ,pp. : 1909-1912

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adjuvant Therapy with Edrecolomab versus Observation in Stage II Colon Cancer: A Multicenter Randomized Phase III Study*

By  

Oncology Research and Treatment, Vol. 28, Iss. 6-7, 2005-06 ,pp. : 347-350

Karger

Access to resources Recommend Favorite